Tivantinib for second-line treatment of advanced hepatocellular carcinoma: a randomised, placebo-controlled phase 2 studyArmando Santoro, Camillo Porta, Ivan Borbath et al.|The Lancet Oncology|2012Cited by 550
Glypican-3 (GPC-3) Structural Analysis and Cargo in Serum Small Extracellular Vesicles of Hepatocellular Carcinoma PatientsMauro Montalbano, Luca Cicalese|International Journal of Molecular Sciences|2023Cited by 17
Transformation of primary human hepatocytes in hepatocellular carcinomaMauro Montalbano, Luca Cicalese|International Journal of Oncology|2015Cited by 11
Modeling of Hepatocytes Proliferation Isolated from Proximal and Distal Zones from Human Hepatocellular Carcinoma LesionMauro Montalbano, Luca Cicalese|PLoS ONE|2016Cited by 11